Dr. Lal Path Labs — Peer Comparison

How the peer fair value is calculated and which companies were used as benchmarks.

Peer selection

Peers are selected from the same Healthcare sector. 8 companies were matched as valid comparables.

Same-industry peers share similar business models, cost structures, and growth prospects — making them the most appropriate benchmarks for valuation multiples. Industry-level matches were unavailable, so sector-level peers were used instead.

Peer comparison table

Healthcare · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Dr. Lal Path Labs LALPATHLAB · you	₹32,238 Cr	63.7×	12.8×	42.8×	20.1%	18.3%	11.1%
Sector median	—	69.8×	9.0×	37.4×	13.4%	9.4%	17.9%
Apollo Hospitals APOLLOHOSP	₹1.2 L Cr	61.1×	12.5×	33.4×	20.5%	7.7%	14.9%
Manipal Health Enterprises Limited MANIPALHOS	₹1.0 L Cr	106.8×	11.3×	42.9×	10.6%	8.6%	28.8%
Max Healthcare Institute MAXHEALTH	₹97,655 Cr	68.0×	9.1×	45.6×	13.4%	17.2%	22.4%
Fortis Healthcare FORTIS	₹74,835 Cr	71.7×	7.5×	37.4×	10.5%	11.4%	13.2%
Aster DM Healthcare ASTERDM	₹40,777 Cr	105.1×	8.9×	47.6×	8.5%	8.4%	15.7%
Narayana Hrudayalaya NH	₹39,489 Cr	47.9×	8.6×	28.2×	17.8%	10.2%	20.4%
Krishna Institute of Medical Sciences KIMS	₹33,983 Cr	126.6×	17.0×	—	13.4%	0.1%	—
Global Health MEDANTA	₹33,396 Cr	60.1×	8.4×	37.0×	14.0%	12.6%	17.9%

Peer comparison verdict

Dr. is fairly valued relative to sector peers — trading near the sector median on key multiples (P/E ~69.8×, EV/EBITDA ~37.4×). Focus on execution quality and earnings trajectory from here.

How the peer fair value is calculated

Three valuation methods are weighted by sector. Each gives a fair value based on how sector peers are currently priced.

Method breakdown

35% weight · 8 peers

Sector median PE69.8×

Fair value via PE₹2,140

25% weight · 8 peers

Sector median PB9.0×

Fair value via PB₹1,373

EV/EBITDA

40% weight · 7 peers

Sector median EV/EBITDA37.4×

Fair value via EV/EBITDA₹1,708

Blended peer fair value₹1,776

Why median? Why these weights?

Median over mean: The sector median is used instead of the average because valuation multiples have extreme outliers — one high-growth company at 200× P/E would dramatically skew a mean. The median gives the middle value in the peer set, which better represents typical pricing.

Sector-specific weights: The weight given to each method reflects what matters most in this sector. For banks, P/B dominates because their value is tied to book assets. For IT companies, P/E carries the most weight because earnings quality matters more than asset base. For capital-intensive businesses, EV/EBITDA accounts for varying debt levels across peers and removes financing structure bias.

Limitations of peer comparison

Peer comparison assumes comparable companies are truly comparable — which is never perfectly true. Sector classifications can be imperfect: a conglomerate classified as "IT" may also have significant manufacturing revenue. Small peer counts (below 5) reduce confidence, as a single outlier can skew the sector median. When the entire sector is broadly expensive, peer comparison will show even an expensive stock as "fairly valued" relative to its peers.

The peer fair value shown is an algorithmic estimate based on publicly available financial data. It is not investment advice or a recommendation to buy, sell, or hold any security. Please consult a SEBI-registered investment adviser before making any investment decision.